6533b82dfe1ef96bd12908b3

RESEARCH PRODUCT

EGFR mutant cfDNA and CTC detection as biomarkers in patients diagnosed with advanced non-small cell lung cancer.

Miguel Angel Molina-vilaNúria Jordana-arizaCarlos CampsEloisa Jantus-lewintreRafael RosellClara Mayo De Las CasasAriadna BaladaSilvia Calabuig-fariñasAna Blasco

subject

Cancer Researchbusiness.industryMutantCancermedicine.diseaseOncologyCancer researchMedicineBiomarker (medicine)In patientNon small cellLiquid biopsybusinessLung cancer

description

e23039Background: One of the most promising developments in translational cancer has been the emergence of liquid biopsy as a non-invasive biomarker. CTCs and cfDNA offer valuable prognostic and pr...

https://doi.org/10.1200/jco.2016.34.15_suppl.e23039